tiprankstipranks
Trending News
More News >
Apimeds Pharmaceuticals US, Inc. (APUS)
:APUS
US Market

Apimeds Pharmaceuticals US, Inc. (APUS) Revenue

Compare
17 Followers

Apimeds Pharmaceuticals US, Inc. Revenue

Apimeds Pharmaceuticals US, Inc. had a revenue of 0.00 in the quarter ending Sep 30, 2025, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2024, Apimeds Pharmaceuticals US, Inc. had annual revenue of 0.00 with ― growth.
Revenue (ttm)
0.00
Revenue Growth
P/S Ratio
Revenue/Employee
$0
Employees
2
Market Cap
$24.52M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021